Business

Coca-Cola Co. Revenue Misses Expectations

Actavis agreed to buy rival drug maker Forest Labs for $25 billion. Plus, key stocks to watch include Coca-Cola and Tesla. MarketWatch's Victor Reklaitis joins the News Hub. Photo: The Coca-Cola Company.

Advertisement—Continue Reading Below

Share